163 results match your criteria: "Raymond-Poincare University Hospital[Affiliation]"

Background And Objectives: Safety and efficacy of IV onasemnogene abeparvovec has been demonstrated for patients with spinal muscular atrophy (SMA) weighing <8.5 kg. SMART was the first clinical trial to evaluate onasemnogene abeparvovec for participants weighing 8.

View Article and Find Full Text PDF

Background: Meropenem-vaborbactam (MEM-VAB) is a novel carbapenem-beta-lactamase-inhibitor combination that demonstrates activity against carbapenem-resistant (CR) Gram-negative bacteria, and more specifically KPC-producers, since vaborbactam is an effective inhibitor of KPC enzymes in vitro. This study aimed to describe the initial uses and efficacy of MEM-VAB for compassionate treatment during the first 21 months following its early access in France.

Method: A national multicenter retrospective study was conducted, including all patients who received at least one dose of MEM-VAB between 20 July 2020, and 5 April 2022.

View Article and Find Full Text PDF

The molecular diagnosis of type 1 facioscapulohumeral muscular dystrophy (FSHD1) relies on the detection of a shortened D4Z4 array at the 4q35 locus. Until recently, the diagnosis of FSHD2 relied solely on the absence of a shortened D4Z4 allele in clinically affected patients. It is now established that most FSHD2 cases carry a heterozygous variant in the SMCHD1 gene.

View Article and Find Full Text PDF

Purpose: Information and communication technologies are crucial for social and professional integration, but access to technology can be difficult for people with physical impairments. Text entry can be slow and tiring. We developed a free and open-source module called for use with AAC (augmentative/alternative communication) software in French language.

View Article and Find Full Text PDF

Background: Myosin heavy chain 7 ()-related myopathies (-RMs) are a group of muscle disorders linked to pathogenic variants in the gene, encoding the slow/beta-cardiac myosin heavy chain, which is highly expressed in skeletal muscle and heart. The phenotype is heterogeneous including distal, predominantly axial or scapuloperoneal myopathies with variable cardiac involvement.

Methods: We retrospectively analysed the clinical, muscle MRI, genetic and myopathological features of 57 patients.

View Article and Find Full Text PDF
Article Synopsis
  • * Nineteen patients were involved, all asymptomatic at diagnosis, with a median age of 3.0 months when treated; all 12 children evaluated achieved new motor milestones including standing and walking independently.
  • * The findings suggest that this treatment leads to improved motor function with manageable adverse events, aligning with previously documented results.
View Article and Find Full Text PDF

Syphilis Should not be Overlooked in any Individual, Irrespective of their Condition.

Eur J Case Rep Intern Med

August 2024

Infectious Disease Department, Raymond-Poincaré University Hospital, AP-HP, Paris Saclay University, Garches, France.

Introduction: Syphilis remains a significant challenge in public health, largely because of its diverse clinical manifestations, often resulting in underdiagnosis especially among patients with neurogenic disability.

Case Description: We present a case of neurosyphilis in a 63-year-old patient with a spinal cord injury. Despite syphilis being a well-established sexually transmitted infection, the exacerbation of neurological and dermatological symptoms during physical examination prompted an investigation into alternative causes beyond the patient's pre-existing paraparesis, ultimately resulting in the diagnosis of neurosyphilis.

View Article and Find Full Text PDF

Introduction: Early focal brain injuries lead to long-term disabilities with frequent cognitive impairments, suggesting global dysfunction beyond the lesion. While plasticity of the immature brain promotes better learning, outcome variability across individuals is multifactorial. Males are more vulnerable to early injuries and neurodevelopmental disorders than females, but long-term sex differences in brain growth after an early focal lesion have not been described yet.

View Article and Find Full Text PDF
Article Synopsis
  • Prosthetic joint infections (PJIs) caused by Candida species are serious complications following joint replacement surgeries, with a study reviewing 269 cases between 2010 and 2021 to assess treatment outcomes.
  • The majority of infections occurred in older patients (average age 73), primarily in hips and knees, and most cases involved additional bacterial infections; roughly 58% achieved a cure at the two-year follow-up.
  • Treatment effectiveness varied significantly depending on the surgical method used, with poorer outcomes linked to the debridement, antibiotics, and implant retention (DAIR) approach and patients older than 70, while infections from Candida parapsilosis tended to have better outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • Late onset Pompe disease (LOPD) is a rare disorder that affects muscle function due to a lack of a specific enzyme, leading to issues such as macroglossia (enlarged tongue) and swallowing difficulties in patients.
  • A study of 100 adult LOPD patients revealed that 32% experienced some level of swallowing difficulties, with 20% dealing with daily dysphagia and 18% facing aspiration risks, yet only a small number were receiving help from speech therapists.
  • The findings suggest that common swallowing problems significantly affect patients' daily lives, highlighting the need for healthcare professionals to be more aware of these symptoms and to provide coordinated care involving specialists like speech therapists and dietitians.
View Article and Find Full Text PDF

2024 update: European consensus statement on gene therapy for spinal muscular atrophy.

Eur J Paediatr Neurol

July 2024

Neuromuscular Reference Center, Department of Pediatrics, University Hospital Liège & University of Liège, Belgium; MDUK Oxford Neuromuscular Centre & NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.

Article Synopsis
  • * One key treatment is the gene therapy called onasemnogene abeparvovec (Zolgensma®), which is effective for patients with specific genetic profiles, although its broad usage raises concerns about safety for less clear cases.
  • * A European expert group has investigated the use of Zolgensma® for older and heavier SMA patients, resulting in 12 consensus statements that reflect the evolving understanding of its effectiveness based on new clinical and real-world evidence.
View Article and Find Full Text PDF
Article Synopsis
  • * This review assesses the evidence for using cefiderocol to treat severe pneumonia caused by CRAB, analyzing studies and trials from 2017 to 2023, while highlighting the complexities in treatment outcomes.
  • * There are conflicting results regarding cefiderocol’s effectiveness, with some studies showing higher mortality rates compared to other treatments, indicating that optimized dosing or combination therapies may be necessary to improve patient outcomes.
View Article and Find Full Text PDF

Percutaneous needle tenotomies: indications, procedures, efficacy and safety. A systematic review.

Ann Phys Rehabil Med

June 2024

Physical and Rehabilitation Medicine Department, University Hospital of Saint-Etienne, 25, boulevard Pasteur, 42100 Saint- Etienne, France; Lyon Neuroscience Research Center, Trajectoires team (Inserm UMR-S 1028, CNRS UMR 5292, Lyon 1 & Saint-Etienne Universities), France.

Background: Percutaneous needle tenotomies constitute a promising approach that enables direct access to tendons through minimally invasive interventions. They can be performed rapidly without need for large incisions or general anaesthesia. However, the reported procedures are heterogeneous and currently conducted without guidelines.

View Article and Find Full Text PDF

[Incidence of urinary tract infection after urodynamics among patients with neurogenic bladder].

Fr J Urol

November 2024

Neuro-Uro-Andrology Department, Raymond-Poincare University Hospital, Garches, France; Faculty of Medicine, Versailles Saint-Quentin University, Montigny-le-Bretonneux, Paris Saclay, France.

Article Synopsis
  • The study investigates the need for prophylactic antibiotics during cystomanometry to prevent urinary tract infections (UTIs) in patients with neurogenic bladder, as existing data on this topic is limited.
  • It involved 100 patients at a neuro-urology center between February and March 2023, with follow-ups conducted via phone to assess UTI occurrence within 14 days after the procedure.
  • Results showed an 11% UTI incidence post-cystomanometry without antibiotics, comparable to rates seen with antibiotic use, suggesting that such prophylactic therapy may not be necessary.
View Article and Find Full Text PDF

Objectives: In this study, we aimed to assess the efficacy of different ways of administration and types of beta-lactams for hospitalized community-acquired pneumonia (CAP).

Methods: In this post-hoc analysis of randomized controlled trials (RCT) on patients hospitalized for CAP (pneumonia short treatment trial) comparing 3-day vs. 8-day durations of beta-lactams, which concluded to non-inferiority, we included patients who received either amoxicillin-clavulanate (AMC) or third-generation cephalosporin (3GC) regimens, and exclusively either intravenous or oral treatment for the first 3 days (followed by either 5 days of oral placebo or AMC according to randomization).

View Article and Find Full Text PDF

Breast cancer is the most common type of cancer among women worldwide. Gastric metastasis from invasive lobular carcinoma of the breast is unusual. We report the case of a 66-year-old woman, under follow-up for an invasive classic lobular carcinoma of the left breast treated four years prior, who was admitted for upper abdominal discomfort and worsening constipation.

View Article and Find Full Text PDF

Peripubertal gynecomastia for Apollo?

Ann Endocrinol (Paris)

July 2024

Department of Epidemiology and Public Health, Raymond Poincaré University Hospital (Assistance publique des Hôpitaux de Paris), 104, boulevard Raymond-Poincaré, 92380 Garches, France; UFR Simone Veil - santé (UVSQ/Paris-Saclay), 2, avenue de la Source de la Bièvre, 78180 Montigny-le-Bretonneux, France. Electronic address:

View Article and Find Full Text PDF
Article Synopsis
  • - About 1% of the global population uses wheelchairs, which puts them at risk for pressure injuries from prolonged sitting; a connected pressure detection system could help prevent these injuries if user needs are understood.
  • - A study surveyed wheelchair users to explore their views on pressure detection systems, revealing that while many users (78.4%) saw the value in such systems, only 17.0% were aware of their existence.
  • - Users favored a pressure warning alarm feature (4.2/5 rating) and preferred personalized alerts based on their habits rather than strict medical guidelines, indicating a need for better awareness and education about available solutions.
View Article and Find Full Text PDF
Article Synopsis
  • Late-onset Pompe disease (LOPD) is a progressive muscle disorder caused by a deficiency in an enzyme, and switching to the drug avalglucosidase alfa has shown promise for patients not responding to the standard treatment, alglucosidase alfa.
  • A study analyzing data from the French Pompe registry found that after switching medications, patients exhibited stabilization in motor function, specifically in the Six-Minute Walk Test, while respiratory function remained largely unchanged.
  • Overall, while most patients experienced a slowdown in the decline of motor abilities after the switch, individual results varied, with some showing improvement and others continuing to decline.
View Article and Find Full Text PDF
Article Synopsis
  • Collagen VI-related dystrophies (COL6-RDs) include a range of conditions such as Ullrich congenital muscular dystrophy (UCMD), which features severe muscle weakness and respiratory issues, and Bethlem muscular dystrophy, which has milder and later-presenting symptoms.
  • Some patients with symptoms typical of COL6-RDs were previously undiagnosed until a deep intronic variant in COL6A1 was identified, leading to a severe form of UCMD in a cohort of 44 patients, except for one with a milder phenotype.
  • The study suggests that a new pseudoexon skipping therapy could effectively reduce the severity of UCMD symptoms by targeting the abnormal transcripts
View Article and Find Full Text PDF

SEPN1-related myopathy depends on the oxidoreductase ERO1A and is druggable with the chemical chaperone TUDCA.

Cell Rep Med

March 2024

Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy; Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy. Electronic address:

Article Synopsis
  • * ERO1A depletion in SEPN1 knockout cells enhances ER redox balance, improves mitochondrial function, and combats diaphragmatic weakness in mice, while ERO1A knockout shows beneficial effects on ER stress and MAM functionality.
  • * ERO1A overexpression is observed in muscle biopsies from SEPN1-RM patients, and the ER stress inhibitor tauroursodeoxycholic acid (TUDCA) improves bio
View Article and Find Full Text PDF
Article Synopsis
  • In 2017, nusinersen, an injectable treatment for spinal muscular atrophy (SMA), was introduced, followed by the oral treatment risdiplam in 2020, leading to questions about appropriate care for adults with SMA due to limited data.
  • To standardize treatment access in France, a national SMA multidisciplinary team meeting (SMDT) was established in 2018 to support decision-making for adult patients.
  • An analysis of 107 patient cases showed that the SMDTs provided various treatment recommendations based on consultations, with most requests aimed at starting new treatments (nusinersen or risdiplam).
View Article and Find Full Text PDF
Article Synopsis
  • Long-term real-world data on the effectiveness and safety of onasemnogene abeparvovec for spinal muscular atrophy (SMA) is crucial for understanding outcomes outside clinical trials.
  • The RESTORE registry tracked 168 patients treated with this therapy, revealing a median age of 3 months at treatment and a majority identified through newborn screening.
  • Results showed all patients maintained or achieved motor milestones, but nearly half experienced at least one adverse event, reinforcing the treatment's safety profile.
View Article and Find Full Text PDF

Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial.

Lancet Infect Dis

May 2024

Institute for Medical Microbiology, Immunology and Hygiene, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany; German Centre for Infection Research, Partner Site Bonn-Cologne, Cologne, Germany; Institute of Translational Research, CECAD Cluster of Excellence, University of Cologne, Cologne, Germany.

Article Synopsis
  • This study investigates the effectiveness and safety of switching from intravenous to oral antibiotics after 5-7 days in patients with low-risk Staphylococcus aureus bloodstream infections.
  • Conducted across 31 hospitals in Europe, the trial aimed to determine if early oral therapy could maintain patient safety and reduce complications compared to ongoing intravenous treatment.
  • Due to slow participant recruitment, the trial was halted early with 215 participants, and the analysis was adjusted to ensure statistical validity, focusing on whether oral treatment led to acceptable complication rates compared with the traditional intravenous approach.
View Article and Find Full Text PDF